Hormone replacement therapy and Alzheimer's disease

Maturitas

Volumn 31, Issue 3, 1999, Pages 201-205

  Van Duijn, Cornelia M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dementia; Estrogen; Menopause

Indexed keywords

ESTROGEN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; ESTROGEN THERAPY; FAMILY HISTORY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE;

AGED; ALZHEIMER DISEASE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; RISK FACTORS;

EID: 0033039874     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00005-5     Document Type: Article

References (32)

1. Van Duijn C.M. Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry. 60:1996;478-488.
2. Slooter AJS, Van Duijn CM. Genetic epidemiology of Alzheimer's disease. Epidemiol Rev 1997;19:107-19.
3. Van Broeckhoven C. Molecular genetics of Alzheimer's disease: Identification of genes and gene mutations. Eur Neurol. 35:1995;8-19.
4. Cruts M., Van Duijn C.M., Backhovens H., Van den Broeck M., Wehnert A., Serneel S. et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of early-onset Alzheimer's disease. Hum Mol Genet. 7:1998;43-51.
5. Luine V.N., Park D., Loh T., Reis D., McEwen B. Immuno-chemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estrodiol administration. Brain Res. 10:1981;122-126.
6. Honjo H., Tanaka K., Kashiwagi T. et al. Senile dementia - Alzheimer's type and estrogen. Horm Metab Res. 27:1995;204-207.
7. Paganini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 140:1994;256-261.
8. Van Duijn C.M., Meijer H., Witteman J.C.M. et al. Estrogen, apolipoprotein E and the risk of Alzheimer's disease. Neurobiol Ageing. 17:1996;79.
9. Heyman A., Wilkinson W.E., Stafford J.A., Helms M.J., Sigmon A.H., Weinberg T. Alzheimer's disease: A study of epidemiological aspects. Ann Neurol. 15:1984;335-341.
10. Amaducci L.A., Fratiglioni L., Rocca W.A., Fieschi C., Livrea P., Pedone D., Bracco L., Lippi A., Gandolfo C., Bino G., Prencipe M., Bonatti M.L., Girotti F., Carella F., Tavolato B., Ferla S., Lenzi G.L., Carolei A., Gambi A., Grigoletto F., Schoenberg B.S. Risk factors for clinically diagnosed Alzheimer's disease: A case-control study of an Italian population. Neurology. 36:1986;922-931.
11. Graves A.B., White E., Koepsell T.D., Reifler B.V., Van Belle G., Larson E.B., Raskind M. A case-control study of Alzheimer's disease. Ann Neurol. 28:1990;766-774.
12. Broe G.A., Henderson A.S., Creasey H., McCusker E., Korten A.E., Jorm A.F., Longley W., Anthony J.C. A case-control study of Alzheimer's disease in Australia. Neurology. 40:1990;1698-1707.
13. Brenner D.E., Kukull W.A., Stergachis A. et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol. 140:1994;262-267.
14. Henderson V.W., Paganini-Hill A., Emanuel C.K. et al. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol. 51:1994;896-900.
15. Mortel K.F., Meyer J.S. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsych Clin Neurosci. 7:1995;334-337.
16. Tang M.X., Jacobs D., Stern Y. et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
17. Lerner A., Koss E., Debanne S. et al. Smoking and estrogen-replacement therapy as protective factors for Alzheimer's disease. Lancet. 349:1997;403-404.
18. Kawas C., Resnick S., Morrison A. et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology. 48:1997;1517-1521.
19. Burns A., Murphy D. Protection against Alzheimer's disease? Lancet. 348:1996;420-421.
20. Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol. 4:1977;31-47.
21. Hackman B.W., Gallbraith D. Six-month study of oestrogen therapy with piperazine oestrone sulphate and its effects on memory. Curr Med Res Opin. 4:1977;21-27.
22. Fedor-Freybergh P. The influence of oestrogen on the well-being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynaecol Scand. 64:1977;65-69.
23. Sherwin B.B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Pyschoneuroendocrinology. 13:1988;345-357.
24. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994;42:919-922.
25. Ditkoff E.C., Crary W.G., Cristo M., Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 78:1991;345-357.
26. Barrett-Connor E., Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. J Am Med Assoc. 269:1993;2637-2641.
27. Fillit H., Weinreb H., Cholst I. et al. Observations in a preliminary open trial of estrodiol therapy for senile dementia - Alzheimer's type. Psychoneuroendocrinology. 11:1986;337-345.
28. Weiss B.L. Failure of nalmefene and estroge to improve memory in Alzheimer's disease. Am J Psychiatry. 144:1987;386-387.
29. Honjo H., Ogino Y., Naitoh K. et al. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer type). J Steroid Biochem Mol Biol. 34:1989;511-515.
30. Ohkura T, Isse K, Akazawa K, et al. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 1994;41:361-371.
31. Ohkura T, Isse K, Akazawa K, et al. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 1995;6:99-107.
32. Birge S.J., Mortel K.F. Estrogen and the treatment of Alzheimer's disease. Am J Med. 103:1997;36s-45.